Danaher to acquire Masimo for $9.9 billion in cash deal Feb 17, 2026 08:02AM
Danaher To Acquire Masimo Corporation Feb 17, 2026 08:00AM
Danaher Reports Fourth Quarter and Full Year 2025 Results Jan 28, 2026 06:00AM
Beckman Coulter Diagnostics Launches Industry First Fully Automated, High Throughput BD-Tau Research Use Only Immunoassay Test, Advancing Neurodegenerative Clinical Research Sep 10, 2025 08:31AM
Danaher (DHR) appoints Greg Milosevich to EVP, Life Sciences Jun 27, 2025 07:31AM
View Older Stories

Jun 27, 2025 07:30AM Danaher appoints Greg Milosevich to Executive Vice President, Life Sciences
Mar 10, 2025 08:30AM Beckman Coulter Announces FDA clearance of DxC 500i Clinical Analyzer, an integrated Clinical Chemistry and Immunoassay System
Jan 15, 2025 08:30AM Beckman Coulter Introduces Cutting-Edge Research Use Only Assays for Neurodegenerative Disease Research
Sep 17, 2024 08:30AM Beckman Coulter and Scopio Labs Add World's First Digital Bone Marrow Imaging and Analysis to Long-Term Partnership
Jul 25, 2024 09:00AM Beckman Coulter's DxI 9000 Immunoassay Analyzer Honored at Premier, Inc.'s Annual Supplier Innovation Celebration
Jul 17, 2024 07:33AM Danaher (DHR) Announces Two New Centers of Innovation in Diagnostics to Transform Precision Medicine Development
Jul 17, 2024 07:30AM Danaher Announces Two New Centers of Innovation in Diagnostics to Transform Precision Medicine Development
Jul 9, 2024 03:00AM Beckman Coulter Introduces New Integrated Chemistry and Immunoassay Analyzer
Jun 19, 2024 07:30AM Danaher appoints Julie Sawyer Montgomery to Executive Vice President for Diagnostics
May 9, 2024 07:00AM Danaher Launches Collaboration with Johns Hopkins University Aiming to Improve Neurological Diagnosis
May 3, 2024 09:06AM Curiox Biosystems and Beckman Coulter Life Sciences Announce a Partnership Combining C-FREE™ Technology with DURA Innovations for Hands-Free Washed Sample Preparation for Flow Cytometry
Jan 9, 2024 07:30AM Danaher, Jennifer Doudna, and Innovative Genomics Institute Launch Danaher-IGI Beacon for CRISPR Cures with Aim to Address Hundreds of Diseases Using Gene-editing Platform Solution
Jul 25, 2023 12:00PM Beckman Coulter's DxI 9000 Immunoassay Analyzer with Increased Assay Development Sensitivity Makes First North American Appearance at 2023 AACC
Jul 25, 2023 11:00AM Beckman Coulter Receives FDA Clearance for DxC 500 AU Chemistry Analyzer, Expanding Portfolio with Proven Six Sigma Performance
Jul 19, 2023 08:30AM Beckman Coulter Connects Scopio Labs Digital Cell Morphology with Hematology Workcell Extending Automated Workflow
Jul 17, 2023 08:30AM Beckman Coulter and Fujirebio Partner to Bolster Access to Patient-friendly, Blood-based Alzheimer’s Disease Test Therapeutics
Jul 17, 2023 08:30AM Beckman Coulter and Fujirebio Partner to Bolster Access to Patient-friendly, Blood-based Alzheimer's Disease Test
May 15, 2023 02:00AM Beckman Coulter Unveils Next Generation Immunoassay Analyzer Enabling Elite Laboratory Performance with No Daily Maintenance
Jan 31, 2023 08:30AM Beckman Coulter and MeMed to Expand Access to Proven Host Immune Response Diagnostic Able to Distinguish Between Bacterial and Viral Infections
Oct 11, 2022 08:35AM Beckman Coulter Acquires Artificial Intelligence Company Providing Evidence-Based Clinical Decision Support for Emergency Departments
Jul 25, 2022 07:41AM Beckman Coulter Partners with Mass General and BARDA to Identify Severe Pediatric Infections in Emergency Departments
Jul 20, 2022 08:00AM Beckman Coulter and Scopio Labs Partner to Accelerate Adoption of Hematology Digital Cell Morphology Platform
Sep 28, 2021 06:00AM Beckman Coulter's new urinalysis solution improves laboratory workflow by significantly reducing manual reviews to 4%(1) and cutting sample processing time by up to 78%(2)
Sep 1, 2021 12:14PM Demaris Mills Appointed President of IDT
Jul 26, 2021 08:30AM Beckman Coulter to Distribute BNP Cardiac Assay to Customers
May 19, 2021 03:15PM Beckman Coulter Launches First Fully Quantitative and Automated COVID-19 IgG Test to Assess Antibody Immune Response Levels
May 19, 2021 03:15PM /C O R R E C T I O N -- Beckman Coulter Diagnostics/
May 4, 2021 09:00AM Beckman Coulter is First Diagnostics Company to Offer Workflow Automation Specifically for Mid-volume Laboratories
Mar 23, 2021 01:55PM Danaher (DHR) Announces Beckman Coulter's SARS-CoV-2 IgG II antibody test receives Emergency Use Authorization from the FDA
Mar 23, 2021 01:53PM Beckman Coulter's SARS-CoV-2 IgG II antibody test receives Emergency Use Authorization from the FDA
Mar 23, 2021 01:53PM /C O R R E C T I O N -- Beckman Coulter Diagnostics/
Mar 18, 2021 02:14PM Beckman Coulter Offers $4/High-throughput Antigen Test to Support U.S. Government Initiative to Expand COVID-19 Testing
Jan 25, 2021 11:44AM Beckman Coulter brings the productivity and efficiency benefits of large volume hematology analyzers to small- and medium-sized labs
Dec 18, 2020 06:26AM Beckman Coulter Launches the First High-Quality, High-Throughput COVID-19 Antigen Test Ideal for Mass Testing in the U.S. (DHR)
Dec 18, 2020 06:00AM Beckman Coulter Launches the First High-Quality, High-Throughput COVID-19 Antigen Test Ideal for Mass Testing in the U.S.
Dec 14, 2020 08:00AM Danaher announces leadership appointment
Nov 23, 2020 08:00AM Beckman Coulter launches its semi-quantitative SARS-CoV-2 IgG II antibody test
Nov 10, 2020 03:00AM Beckman Coulter launches its SARS-CoV-2 IgM antibody test in countries accepting CE Mark and will begin shipping to diagnostics labs
Oct 15, 2020 08:00AM Beckman Coulter receives BARDA funding to validate Monocyte Distribution Width in the rapid detection of Multisystem Inflammatory Syndrome (MIS-C), a severe COVID-19 complication in Children
Oct 9, 2020 08:00AM Beckman Coulter SARS-CoV-2 IgM Antibody Test Receives FDA Emergency Use Authorization
Oct 6, 2020 06:00AM Beckman Coulter Completes First In A Series Of Antibody Neutralization Studies
Oct 1, 2020 02:32PM Danaher (DHR) Reports FDA Emergency Use Authorization awarded to the Beckman Coulter Access IL-6 test
Oct 1, 2020 02:30PM FDA Emergency Use Authorization awarded to the Beckman Coulter Access IL-6 test
Sep 15, 2020 09:00AM Beckman Coulter Lauded by Frost & Sullivan for Accelerating Sepsis Detection with the DxH 690T
Aug 24, 2020 08:00AM Beckman Coulter Launches SARS-CoV-2 IgM Antibody Test and will begin shipping to U.S. Diagnostics Labs
Aug 5, 2020 08:30AM Study shows patients with abnormal values of Beckman Coulter's novel MDW biomarker are four- to six- times more likely to be diagnosed with (or develop) sepsis
Jul 23, 2020 08:00AM Beckman Coulter's Automated Blood Banking Analyzer Receives 510(k) FDA Clearance
Jul 21, 2020 04:52PM Beckman Coulter Wins SelectScience Awards for Best New Clinical Instrumentation and Customer Service of the Year
Jul 17, 2020 09:15AM Beckman Coulter Receives Nine IMV ServiceTrak™ Clinical Laboratory Awards
Jul 6, 2020 08:00AM Beckman Coulter, Lenco Diagnostic Laboratories deliver more than 20,000 highly accurate COVID-19 antibody tests each week to New York City; Congressman Max Rose and Brooklyn Borough President Eric Ada
View Older Stories